Bharat Dynamics Q4 Results Net Profit Drops 59 YoY to 113 Crore Final Dividend of 040 Announced Best HighYield Savings Rates on May 27 2026 Top APY Reaches 410 Germanys UltraRich Gap Widens 5000 Individuals Control Over 25 of National Financial Wealth SP 500 Edges Higher as Healthcare and Tech Lead Comms Stands Alone Treasury Yields Edge Lower as Iran Peace Deal Optimism Tempers Geopolitical Concerns Avista Healthcare Partners and Damier Group Acquire sanotact Group with Legal Counsel from White Case CBSH Q1 2026 Earnings EPS Surpasses Estimates by 71 Amid Solid Operating Performance DBX Q1 2026 Earnings EPS Beats Estimates Stock Rises FCFS Q1 2026 Earnings DoubleDigit EPS Beat Drives Modest Share Gains MSGE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher US Energy Corp USEG Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally ABX Q1 2026 Earnings Marginal EPS Miss Amid Positive Stock Reaction Definium Therapeutics DFTX Gains on Strength Approaching Key Resistance Space Asset Acquisition Corp Units SAAQU Holds Steady Near Resistance Awaiting Catalyst American Exceptionalism Acquisition Corp A AEXA Slips 19 as SPAC Faces Resistance Near 12 ARS Pharmaceuticals Inc SPRY Gains 4 as Shares Approach Key Resistance Level Matinas Biopharma MTNB Rises 518 as Biotech Sector Gains Momentum Microsofts New Trusted Technology Lead Jenny LayFlurrie Navigates Tension Between AI Speed and Responsibility Universal Logistics Holdings Inc ULH Q1 2026 Earnings Significant EPS Miss Amid Operational Headwinds Organogenesis Holdings ORGO Holds Steady at 266 Consolidation Phase in Play NTZ Q4 2011 Earnings Significant EPS Miss as Company Reports WiderthanExpected Loss PNR Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Stock Slips Tidewater Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3 SFST Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher FLG Q1 2026 Earnings EPS Surprises to the Upside Amid Lingering Market Concerns MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue